Relates to dihydropyrimidine dehydrogenase deficiency testing
Summary
Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.
Bill status
passed
3 of 5 stages cleared
Introduction
Feb 2018
Committee Review
Jun 2018
Senate Passage
Jun 2018
Assembly Passage
Governor
Introduced Feb 9, 2018
Last action Jun 19, 2018
Floor votes · Senate Jun 19, 2018
How they voted
62–0
Passed · 1 other
Total votes 63
Jun 19, 2018
D
Democratic32
100% Yea
R
Republican31
96% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
6
Key actions
1
Committee
3
Jun 19, 2018
Assembly · Referred to committee
REFERRED TO HEALTH
Jun 19, 2018
Senate · Passed
PASSED SENATE
Jun 19, 2018
Senate · Referred to committee
REFERRED TO RULES
Feb 9, 2018
Senate · Referred to committee
REFERRED TO HEALTH
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about S 7710
Scope: NY
Hi! I can help you understand S 7710. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline